|
Match
|
Document |
Document Title |
|
|
6150410 |
pH independent extended release pharmaceutical formulation
Pharmaceutical formulations of acidic pharmacologic agents which demonstrate improved uniformity of release over the wide range of pH values encountered between the stomach and intestinal tract...
|
|
|
6149940 |
Tablet with controlled release of alfuzosine chlorhydrate
Pharmaceutical tablet which consists of: a) a first layer having the property of swelling considerably and quickly on contact with aqueous biological fluids, the first layer being produced by...
|
|
|
6150424 |
Solid foamed active substance preparations
Solid foamed active ingredient preparations based on melt-processable polymers, obtainable by extrusion of a melt of one or more polymers which comprises active ingredient and which is impregnated...
|
|
|
6143798 |
Wound dressing
The invention provides compositions suitable for use as a wound dressings for blisters, corns and calluses or as fixation adhesives, especially for breast prostheses, ostomy devices and male...
|
|
|
6143315 |
Biochemical contact lens for treating injured corneal tissue
Methods for treating injured corneal tissue are described. The methods include contacting injured corneal tissue with a contact lens which includes an amniotic composition such that scarring of the...
|
|
|
6136334 |
Medical uses of in situ formed gels
Balanced pH, hyperosmotic, hypoosmotic, or isoosmotic gels are ideal vehicles for drug delivery. They are especially suited for topical body cavity or injection application of drugs or diagnostic...
|
|
|
6129931 |
Controlled-release, drug-delivery tableted composition including a complex between poly(maleic diacid-alkyl vinyl ether) and polyvinylpyrrolidone
A pH-dependent, controlled-release, drug delivery composition is described herein which includes: (a) a complex between poly(maleic diacid-alkyl vinyl ether) and polyvinylpyrrolidone, or their...
|
|
|
6126970 |
Cisapride sustained release
|
|
|
6126959 |
Pharmaceutical composition for treating dysmenorrhea and premature labor
The present invention teaches a composition comprising a β-adrenergic agonist in a bioadhesive carrier. Preferably, the composition comprises terbutaline in polycarbophil. The present invention...
|
|
|
6123931 |
Polyurethane and polyacryl nail polish compositions
The present invention relates to compositions useful as cosmetic or therapeutic agents, as well as methods of their use. The compositions herein are particularly useful as coatings for mammalian...
|
|
|
6124037 |
Articles coated with in vivo polymerizable ophthalmic compositions
Coatings for surgical instruments which comprise substituted fluoroalkyl or perfluoroalkyl monomers having anionic, cationic, and/or nonionic surface active functionality in the unsaturated...
|
|
|
6120781 |
Cosmetic or dermopharmaceutical composition in the form of a soft paste and process for preparing the said composition
The present invention relates to a cosmetic or dermopharmaceutical composition in the form of a soft paste, which can be used for making up or treating the skin or lips, comprising, in a fatty...
|
|
|
6120803 |
Prolonged release active agent dosage form adapted for gastric retention
The present invention is directed to an active agent dosage form which is adapted for retention in the stomach and useful for the prolonged delivery of an active agent formulation to a fluid...
|
|
|
6120789 |
Non-polymeric sustained release delivery system
The invention relates to a method and composition for forming an implant in-situ within a body using non-polymeric materials, and the use of such implants as medical devices and drug delivery...
|
|
|
6117444 |
Polyethylene glycol/microfibrillar collagen composite serves as a resorbable hemostatic agent
A resorbable hemostatic agent comprising a delivery component, that aids in the delivery to the wound site, and a microfibrillar hemostatic component that controls bleeding in solid tissue and does...
|
|
|
6117451 |
Direct compression metformin hydrochloride tablets
Metformin Hydrochloride (herein referred to as metformin HCl) that may be 98.5%-100% pure is a high dose drug capable of being directly compressed with specific excipients into tablets having...
|
|
|
6114301 |
2,4,6-trimethyl-4-phenyl-1,3-dioxane
There is described a compound of general formula (2RS,4SR,6X)-2,4,6-Rimethyl-4-phenyl-1,3-dioxane with the configuration characteristic X=RS (Compound 1) or SR ##STR1## The compounds 1 and 3...
|
|
|
6110497 |
Pharmaceutical formulations
Tablet formulations having a structure comprising compacted granulates of a mixture of a medicament and an intra-granular disintegrant, the granulates being compacted together into a tablet with an...
|
|
|
6106863 |
Sustained-release metal valproate tablets
The present invention provides a sustained-release metal valproate tablet which is comparatively compact and is not influenced by a meal, the sustained-release metal valproate comprising a core...
|
|
|
6107347 |
Bimodal molecular weight hyaluronate formulations and methods for using same
Compositions and methods useful for protecting human or animal eye cell layers and tissues exposed to trauma, e.g., during surgery, are disclosed. In one embodiment, the method comprises...
|
|
|
6107344 |
Aqueous germicidal film forming composition for applying to teats of dairy cows
Aqueous film forming compositions are disclosed that are to be applied to the teats of dairy animals to form a protective film on the teats. The protective film may be applied as a dip or spray....
|
|
|
6103271 |
Microencapsulation and electrostatic processing method
Methods are provided for forming spherical multilamellar microcapsules having alternating hydrophilic and hydrophobic liquid layers, surrounded by flexible, semi-permeable hydrophobic or...
|
|
|
6103269 |
Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies
The invention relates to accurately meterable shaped articles, for example granules or pellets, containing hydrophilic macromolecules, active compounds and optionally further pharmaceutically...
|
|
|
6103264 |
Process for preparing a controlled release composition
A process for preparing a controlled release composition with a controlled release matrix and containing a pharmaceutically active ingredient, which comprises granulating the active ingredient with...
|
|
|
6099854 |
Dry composition containing flavonol useful as a food supplement
A flavonol-containing dry composition derived from wine and useful as a food supplement is provided wherein at least 25% of the composition derived from wine includes polyphenols and at least 1.0%...
|
|
|
6086633 |
Method for preserving animal hides
Compositions and methods for preserving untanned animal hides, wherein the compositions comprise 50-95% (w/w) of a polyether antibiotic and 5-25% (w/w) of a surface-acting agent. In these...
|
|
|
6083531 |
Fast disintegrating oral dosage form
|
|
|
6083996 |
Topical compositions for NSAI drug delivery
An aqueous pharmaceutical composition of a semi-solid consistency is provided for topical application of non-steroidal anti-inflammatory (NSAI) drugs. The composition comprises one or more NSAI...
|
|
|
6080793 |
Cosmetically/pharmaceutically/hygienically-active supple doughs comprising heat-sensitive compounds
Cosmetic/pharmaceutical/hygienic compositions (e.g., lipcolors) are formulated as homogeneous and stable, supple dough extrudates, said supple dough extrudates having at least one...
|
|
|
6080426 |
Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
A process for encapsulation of caplets in a capsule comprises the following steps: a. providing empty capsule parts; b. filling at least one of said capsule parts with one or more caplets; c....
|
|
|
6071536 |
Gelatin capsule having adjusted water activity
|
|
|
6071958 |
Ophthalmic carrier solution
This invention refers to a matter composition of the type used in the treatment of ophthalmic ailments and specifically refers to an ophthalmic carrier solution based on surface-active,...
|
|
|
6066668 |
Formulations and methods of reducing toxicity of antineoplastic agents
This invention provides for pharmaceutical formulations of compounds which are useful as protective agents when administered to patients also receiving antineoplastic drugs. The invention also...
|
|
|
6066334 |
Use of redispersible polymer powders or polymer granules as binders for producing solid pharmaceutical presentations
Redispersible polymer powders or polymer granules consisting of a) 10-95% by weight of polyvinyl acetate, b) 5-90% by weight of an N-vinylpyrrolidone-containing polymer, c) 0-20% by weight...
|
|
|
6063406 |
Skin care compositions
The present invention includes a process and composition for treating skin disorders. The composition of the present invention comprises 94.0 to 99.2 percent by weight of cation-free water, 0.1 to...
|
|
|
6063821 |
Transparent rapid release compositions of non-steroidal analgesics
Transparent rapid release active substance compositions obtainable by extrusion of melts, containing non-steroidal analgesics, homopolymers of N-vinylpyrrolidone, saccharides or sugar alcohols and...
|
|
|
6060547 |
Film forming foundation
The invention is a water-in-oil emulsion film forming foundation having a synergistic combination of about 0.5% to about 10% by weight of a water soluble or water dispersible film forming polymer,...
|
|
|
6060518 |
Polymer compositions for chemotherapy and methods of treatment using the same
Improved antineoplastic compositions comprising an antineoplastic agent combined with a pluronic and a water-soluble non-toxic homopolymer resulting in a decrease of toxicity and/or an increase in...
|
|
|
6060546 |
Non-aqueous silicone emulsions
A non-aqueous silicone emulsion containing a silicone phase and an organic phase is useful as a component in various personal care compositions. The silicone phase contains a crosslinked silicone...
|
|
|
6057374 |
Composition, device, and method for electrotransport agent delivery
An electrotransport drug-containing composition is provided. The composition includes a drug to be delivered through a body surface (eg, skin) of a patient, and a permeation enhancer which is solid...
|
|
|
6054451 |
Analgesic composition and method for alleviating pain
The analgesic effectiveness of an analgesic selected from the group consisting of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine, (S)-5-(2-azetidinylmethoxy)-2-chloropyridine and pharmaceutically...
|
|
|
6054492 |
Fluorinated copolymeric pharmaceutical adjuncts
Block copolymers containing a fluorinated hydrocarbon unit, a hydrocarbon unit, and a poly(oxyethylene) unit are useful in fluid formulations of pharmaceutical agents. A typical embodiment is: C...
|
|
|
6051255 |
Polymer coated tablet comprising amoxycillin and clavulanate
The present invention is to a tablet formulation, being a medicament for oral administration for the treatment of bacterial infections, the tablet comprising a compacted mixture of 750-950 mg of...
|
|
|
6046243 |
Compositions for sustained release of a gas
A composite for retarding microbiological contamination containing a hydrophobic material containing an acid releasing agent, and a hydrophilic material containing anions that are capable of...
|
|
|
6045783 |
Cosmetic formulation with a swelling effect
A cosmetic formulation with a swelling or volumizing effect, for use especially as a lipstick or other type of cosmetic, comprising: a) a sodium polyacrylate polymer that swells numerous times...
|
|
|
6042820 |
Biodegradable copolymer containing α-hydroxy acid and α-amino acid units
Copolymers designed for use as particulate carriers containing functionalizable amino subunits for coupling with targeting ligand are described. The copolymers are polyesters composed of α-hydroxy...
|
|
|
6039965 |
Surfanctants for reducing bacterial adhesion onto surfaces
A method for inhibiting microbial colonization of a surface in contact with an aqueous system is disclosed, which comprises adding to the system an amount of at least one compound including...
|
|
|
6037328 |
Method and composition for rewetting and preventing deposits on contact lens
The present invention is directed to an ophthalmic solution for the treatment of contact lenses while worn in the eye. In particular, the composition contains ethoxylated glucose derivative,...
|
|
|
6037387 |
Blood-compatible material of a supramolecular structure
A platelet metabolism suppressing blood compatible material has a supramolecular structure containing a plurality of cyclic compounds and a hydrophilic straight-chain polymer threading into...
|
|
|
6037374 |
Composition and method for the control of parasitic mites in honey bees
Gel compositions of formic acid and a gelling agent such as fumed silica or polyacrylic acid have been prepared for controlling parasitic mites of honey bees. The gels provide slow-release...
|